In this report, the Association of Directors of Anatomic and Surgical Pathology (ADASP) provides guidelines for the reporting of lymphoid neoplasms. The World Health Organization Classification of Tumors of the Haematopoietic and Lymphoid Tissues is the preferred international standard for diagnostic criteria (disease definition) and nomenclature. Ancillary studies are often required, and the Association recommends that immunophenotypic and genotypic information be integrated into the final report, to the extent possible.
The Association of Directors of Anatomic and Surgical Pathology (ADASP) has named several committees to develop recommendations regarding the content of the surgical pathology report for common malignant tumors. A committee of individuals with special interest and expertise write the recommendations, which are reviewed by the council of ADASP and subsequently by the entire membership.
The recommendations have been divided into the following four major areas: (1) items that provide an informative gross description; (2) additional diagnostic features that are recommended to be included in every report if possible; (3) optional features that may be included in the final report; and (4) a checklist.
Features the Association recommends to be included in the final report

Background Clinical Information
The Association recommends the inclusion of pertinent clinical history, when this information is available. The pathologist is encouraged to obtain clinical history, if possible. For some diseases, an accurate history may be essential to diagnosis, for example, post-transplant-associated lymphoproliferative disease. 
Previous diagnosis of a lymphoid neoplasm
Gross Description
The proper handling of the lymph node biopsy specimen is critical to ensure proper fixation, which is essential for the preparation of high-quality histological sections. 1 The Association recommends that the pathologist receive lymph node biopsies fresh, intact, and that an unsectioned lymph node biopsy should never be immersed in fixative. It is recommended that each laboratory establish a protocol for the handling of lymph node biopsies that ensures both optimal histological sections and preservation of material for ancillary studies. These principles, and the procedures outlined below, also apply to extranodal sites that may be biopsied or resected for a potential diagnosis of lymphoma. Tables  1-4) . 3 The designation of morphologic or clinical variants is considered optional for most clinical purposes. If an alternative classification scheme is used, it should be so specified in the diagnosis. 4. Specify if the specimen is only focally or incompletely involved. 5. Specify if more than one histologic type is identified ie, composite lymphoma, or progression to lymphoma of higher histologic grade). 6. Specimen adequacy. A precise diagnosis may not be possible in some instances due to limitations of specimen adequacy (eg, needle biopsy, necrotic or fibrotic specimen). If specimen adequacy is of concern, this fact should be stated explicitly. 7. If ancillary studies (eg, immunocytochemistry, molecular diagnostics) were performed, the diagnosis or comment should contain a statement regarding these studies and their diagnostic implications ( Table 5 ).
Features that may be optional in the final report
Immunophenotypic Information
For many subtypes of lymphoid neoplasms (eg, peripheral T-cell lymphomas, diffuse large B-cell lymphomas, precursor B-cell lymphoblastic lymphoma/leukemia), immunophenotypic studies are essential to accurate diagnosis. 4, 5 In some instances, immunophenotypic studies may not be required (eg, many instances of follicular lymphoma). If immunophenotypic studies are performed, we recommend that the results be included in an integrated single report (Table 6) . 6 If ancillary studies are performed in a reference laboratory, the results should be discussed in an integrated report, and the reference laboratory report appended. 9. A discussion of the significance of the immunophenotypic studies is recommended.
Molecular Genetic Studies
Molecular genetic studies may provide useful diagnostic information about the clonality of the lymphoid infiltrate, the lineage of the lymphoid cells, or a precise molecular abnormality associated with a specific disease. As with immunophenotypic studies, if molecular analysis is performed, the Association recommends that this information be discussed in the context of the histological findings, if possible. Important information to include is:
1. Type of specimen used for the study (frozen tissue vs paraffin-embedded specimen (monoclonal, polyclonal, oligoclonal) and its possible diagnostic significance.
Viral Studies
Viruses are important cofactors for many lymphoma types, and corroboration of a viral association may be essential for the diagnosis of some diseases, such as adult T-cell leukemia/lymphoma (HTLV-I) or primary effusion lymphoma (HHV-8/KSHV). The pathologist should state the method of identifica- 
Cytogenetic Studies
Cytogenetic studies may provide ancillary diagnostic information useful in the diagnosis or subclassification of lymphoma. The identification of a clonal cytogenetic abnormality supports a diagnosis of malignancy. Some cytogenetic abnormalities are highly associated with specific lymphoid malignancies, for example t(14;18) with follicular lymphoma. The Association recommends that the cytogenetic data be discussed in the context of the histological findings and the complete report appended to the Surgical Pathology report.
1. Conventional cytogenetics. 2. Fluorescence in situ hybridization.
